- D18.1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM D18.1 became effective on October 1, 2022.
- This is the American ICD-10-CM version of D18.1 – other international versions of ICD-10 D18.1 may differ.
ICD-10-CM D18.1 is grouped within Diagnostic Related Group(s):
- 814 Reticuloendothelial and immunity disorders with mcc
- 815 Reticuloendothelial and immunity disorders with cc
- 816 Reticuloendothelial and immunity disorders without cc/mcc
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2016 (effective 10/1/2015): No change
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2024 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to D18.1:
- lymphangiomatous > Cyst (colloid) (mucous) (simple) (retention)
- capillary > Lymphangioma D18.1
- cavernous > Lymphangioma D18.1
- cystic > Lymphangioma D18.1
- lymphatic > Nevus D22.9